Key Takeaways
- • Tiger Global deployed a "spray-and-pray" investment strategy during the pandemic venture boom, becoming the world's most prolific venture investor in 2021 with nearly one deal per day, backed by a $6.65 billion fund closed that year and a $12.7 billion fund raised in early 2022.
- • Indian startup valuations surged dramatically during the pandemic, with venture capital flowing into the country increasing from a record $10 billion in 2019 to nearly $40 billion by 2021, creating 44 new unicorns in a single year as lockdowns accelerated digital adoption and China's tech crackdown redirected investor focus.
- • Tiger Global distinguished itself through aggressive late-stage funding that inflated company valuations, minimal board oversight, hands-off management approach, and rapid capital deployment across global tech startups at all lifecycle stages.
- • Recent fund performance shows Tiger Global's $12.7 billion 2021 fund is up 16% in the current year, while a smaller subsequent fund has returned 33%, suggesting selective recovery despite the broader venture market downturn from pandemic-era peaks.
- • The firm's hyperaggressive investment approach during the Covid-era bubble period contributed to unsustainable unicorn valuations and subsequent market corrections, raising questions about venture capital's role in fueling cyclical hype cycles.
Summary
Tiger Global emerged as a dominant force in global venture capital during the pandemic, leveraging a distinctive investment philosophy characterized by speed, scale, and minimal operational involvement. The New York-based hedge fund and venture firm became known for its "spray-and-pray" methodology—deploying massive capital across numerous deals in the expectation that a small number would generate outsized returns. This approach proved particularly potent during the Covid-19 era, when Tiger Global secured the position of the world's most prolific venture investor in 2021, completing nearly one deal daily. The firm closed a $6.65 billion fund that year and subsequently raised a $12.7 billion fund in early 2022, deploying capital at unprecedented velocity.
The timing coincided with an extraordinary expansion of venture capital flows into emerging markets, particularly India. Venture funding into Indian startups surged from a record $10 billion in 2019 to nearly $40 billion by 2021, fueled by pandemic-driven digitalization, supply chain relocations away from China following Beijing's tech crackdowns, and a broader search for growth opportunities outside mature markets. This capital influx generated 44 new unicorns—private companies valued at $1 billion or more—in 2021 alone, with Tiger Global and other tier-one firms including Sequoia, SoftBank, and Accel participating aggressively.
Tiger Global's distinctive competitive advantage lay in its willingness to write exceptionally large checks at late-stage valuations without assuming traditional board seats or operational oversight responsibilities. The firm's hands-off approach and appetite for inflating company valuations through competitive bid rounds differentiated it from more cautious venture peers. Founders actively courted the firm, viewing Tiger Global capital as validation and fuel for accelerated growth. However, this investment model—while generating impressive deployment metrics and paper gains during the boom—raised questions about underlying fundamental valuations and business sustainability as pandemic-era conditions normalized.
Current performance metrics suggest selective recovery from peak pandemic enthusiasm. Tiger Global's $12.7 billion 2021 fund has appreciated 16% in the current year, while a smaller subsequent fund has generated 33% returns. These gains reflect partial recovery from significant 2022-2023 drawdowns but remain well below the venture sector's historical return benchmarks. The divergence between Tiger Global's rise during the pandemic bubble and its subsequent performance underscores broader venture capital dynamics: hyperaggressive capital deployment during inflated valuation environments can generate substantial losses when market conditions contract, particularly for late-stage investments with limited margin for error.
The timing coincided with an extraordinary expansion of venture capital flows into emerging markets, particularly India. Venture funding into Indian startups surged from a record $10 billion in 2019 to nearly $40 billion by 2021, fueled by pandemic-driven digitalization, supply chain relocations away from China following Beijing's tech crackdowns, and a broader search for growth opportunities outside mature markets. This capital influx generated 44 new unicorns—private companies valued at $1 billion or more—in 2021 alone, with Tiger Global and other tier-one firms including Sequoia, SoftBank, and Accel participating aggressively.
Tiger Global's distinctive competitive advantage lay in its willingness to write exceptionally large checks at late-stage valuations without assuming traditional board seats or operational oversight responsibilities. The firm's hands-off approach and appetite for inflating company valuations through competitive bid rounds differentiated it from more cautious venture peers. Founders actively courted the firm, viewing Tiger Global capital as validation and fuel for accelerated growth. However, this investment model—while generating impressive deployment metrics and paper gains during the boom—raised questions about underlying fundamental valuations and business sustainability as pandemic-era conditions normalized.
Current performance metrics suggest selective recovery from peak pandemic enthusiasm. Tiger Global's $12.7 billion 2021 fund has appreciated 16% in the current year, while a smaller subsequent fund has generated 33% returns. These gains reflect partial recovery from significant 2022-2023 drawdowns but remain well below the venture sector's historical return benchmarks. The divergence between Tiger Global's rise during the pandemic bubble and its subsequent performance underscores broader venture capital dynamics: hyperaggressive capital deployment during inflated valuation environments can generate substantial losses when market conditions contract, particularly for late-stage investments with limited margin for error.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.